An Immunoinformatics-Based Multi-Peptide Vaccine Provides Antibody-Mediated Protection Against Acinetobacter...

Area of Science:

• Vaccinology
• Immunology
• Infectious Diseases

Background:

• Acinetobacter baumannii is a multidrug-resistant (MDR) pathogen causing significant mortality and healthcare costs.
• An immunoinformatics-designed vaccine candidate, AMEV2, previously showed protection against MDR A. baumannii.

Purpose of the Study:

• To elucidate the immunological mechanisms underlying AMEV2-mediated protection.
• To evaluate the role of antibody-mediated immunity in AMEV2's efficacy.

Main Methods:

• Passive immunization with AMEV2 antisera in a mouse model.
• In vitro opsonophagocytic killing assays (OPKAs) using macrophages.
• Antibody depletion assays targeting specific vaccine components.

Main Results:

• Passive transfer of AMEV2 antisera conferred 67% protection against A. baumannii pulmonary challenge.
• AMEV2 antibodies enhanced bacterial clearance via complement and Fc gamma receptor-mediated phagocytosis.
• A key peptide, pTonB, elicited protective antibodies, and its depletion reduced vaccine efficacy.

Conclusions:

• Humoral immunity and antibody-mediated phagocytosis are crucial for AMEV2's protective effect.
• In silico-designed vaccines offer a promising strategy against global MDR pathogen threats.